Biomapas is a biotechnology company founded in 2001 and headquartered in Lithuania. The company’s slogan, "A complete spectrum of Clinical Research, Regulatory Affairs, Pharmacovigilance and Medical Information solutions," reflects its core services and offerings.
Biomapas positions itself as a functional and full outsourcing solution provider to the global life science industry, catering to biopharmaceutical, medical device, cosmetics, and food supplement companies. It prides itself on offering one-stop-shop clinical research capabilities in high recruiting countries, with a focus on delivering regulatory and pharmacovigilance excellence across Europe, CIS, MENA, and LATAM regions throughout the entire product lifecycle.
The company emphasizes its in-house experience and hands-on mindset, which enables it to provide tailored solutions to complex challenges that may arise during the path to commercialization. Biomapas' professionals aim to execute projects efficiently and cost-effectively while striving to become integral partners from Early Development to Commercial success. Additionally, the company maintains a social media privacy policy which can be found at bit.ly/privacy-biomapas.
It is noteworthy that the information on the company's last investment and the investors involved is currently unavailable.
There is no investment information
No recent news or press coverage available for Biomapas .